Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Aug;93(8):935–943. doi: 10.1111/j.1349-7006.2002.tb01340.x

Calponin h1 Suppresses Tumor Growth of Src‐induced Transformed 3Y1 Cells in Association with a Decrease in Angiogenesis

Miwako Kaneko 1, Michiko Takeoka 2, Misae Oguchi 1, Yoko Koganehira 1, Hiroshi Murata 1, Takashi Ehara 3, Minoru Tozuka 4, Toshiaki Saida 1, Shun'ichiro Taniguchi 2,
PMCID: PMC5927104  PMID: 12716472

Abstract

Calponin h1 (CNhl) is a basic actin‐binding protein that is abundantly expressed in smooth muscle cells and involved in smooth muscle contraction by inhibiting actomyosin MgATPase. In recent studies, CNhl was noted to suppress cell proliferation and tumorigenicity in leiomyosarcoma and tumor growth in fibrosarcoma cell lines. To further investigate the function of CNhl as a tumor suppressor, we transfected the human CNhl gene into a v‐src‐transformed rat fibroblast cell line SR–3Y1. The volume of the tumors derived from one randomly selected CNh1‐transfectant (C1) in nude mice was reduced to 34.1% of that from a randomly selected vector transfectant (VI). A similar tendency was observed in another independent pair (C2, V2). Pathological analysis showed a significant decrease in the number of mitotic cells in the CNh1‐transfectants. Further, a marked reduction in the number of vessels in the CNhl‐transfectant was observed. DNA synthesis under conditions without serum was significantly reduced in the CNhl‐transfectant (C1) compared with the control transfectant (VI), while no significant difference was seen in the cellular growth in the presence of 10% serum. A slight but significant reduction in in vitro cellular motility in the CNhl‐transfectant was also observed. While the suppression of growth potential and cell motility by CNhl transfer was significant but partial, a marked reduction in vascular endothelial growth factor (VEGF) mRNA and the secretion of VEGF protein was observed in the CNhl‐transfectant. These results suggest that CNhl plays a role as tumor suppressor in SR–3Y1 mainly by decreasing VEGF expression and angiogenesis in vivo and partially through reducing cellular proliferative potential and cell motility.

Keywords: Calponin, Tumor growth, Angiogenesis, Vascular endothelial growth factor, DNA synthesis

Full Text

The Full Text of this article is available as a PDF (5.9 MB).

REFERENCES

  • 1. ) Takahashi , K. , Hiwada , K. and Kokubu , T.Isolation and characterization of a 34000–dalton calmodulin‐and F‐actinbinding protein from chicken gizzard smooth muscle . Biochem. Biophys. Res. Commun. , 141 , 20 – 26 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Winder , S. and Walsh , M.Calponin. Curr. Top. Cell. Regul. , 34 , 33 – 61 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Duband , J. L. , Gimona , M. , Scatena , M. , Sartore , S. and Small , J. V.Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development . Differentiation , 55 , 1 – 11 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Kake , T. , Kimura , S. , Takahashi , K. and Maruyama , K.Calponin induces actin polymerization at low ionic strength and inhibits depolymerization of actin filaments . Biochem. J. , 312 , 587 – 592 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Horiuchi , A. , Nikaido , T. , Ito , K. , Ya‐Li , Z. , Orii , A. , Taniguchi , S. , Toki , T. and Fujii , S.Reduced expression of calponin h1 in leiomyosarcoma of the uterus . Lab. Invest. , 78 , 839 – 846 ( 1998. ). [PubMed] [Google Scholar]
  • 6. ) Horiuchi , A. , Nikaido , T. , Taniguchi , S. and Fujii , S.Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma . J. Natl. Cancer Inst. , 91 , 790 – 796 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Takeoka , M. , Ehara , T. , Sagara , J. , Hashimoto , S. and Taniguchi , S.Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells . Eur. J. Cancer , 38 , 436 – 442 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Yamamura , H. , Yoshikawa , H. , Tatsuta , M. , Akedo , H. and Takahashi , K.Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis . Int. J. Cancer (Pred. Oncol.) , 79 , 245 – 250 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Yamamura , H. , Hashio , M. , Noguchi , M. , Sugenoya , Y. , Osakada , M. , Hirano , N. , Sasaki , Y. , Yoden , T. , Awata , N. , Araki , N. , Tatsuta , M. , Miyatake , S. and Takahashi , K.Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors . Cancer Res. , 61 , 3969 – 3977 ( 2001. ). [PubMed] [Google Scholar]
  • 10. ) Jiang , Z. , Grange , R. W. , Walsh , M. P. and Kamm , K. E.Adenovirus‐mediated transfer of the smooth muscle cell calponin gene inhibits proliferation of smooth muscle cells and fibroblasts . FEBS Lett. , 413 , 441 – 445 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Taniguchi , S. , Takeoka , M. , Ehara , T. , Hashimoto , S. , Shibuki , H. , Yoshimura , N. , Shigematsu , H. , Takahashi , K. and Katsuki , M.Structural fragility of blood vessels and peritoneum in calponin h1–deficient mice resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells . Cancer Res. , 61 , 7627 – 7634 ( 2001. ). [PubMed] [Google Scholar]
  • 12. ) Mukhopadhyay , D. , Tsiokas , L. , Zhou , X. , Foster , D. , Brugge , J. S. and Sukhatme , V. P.Hypoxic induction of human vascular endothelial growth factor expression through c‐Src activation . Nature , 375 , 577 – 581 ( 1099. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Mukhopadhyay , D. , Tsiokas , L. and Sukhatme , V. P.Wildtype p53 and v‐src exert opposing influences on human vascular endothelial growth factor gene expression . Cancer Res. , 55 , 6161 – 6165 ( 1995. ). [PubMed] [Google Scholar]
  • 14. ) Tanaka , H. , Zaitsu , H. , Onodera , K. and Kimura , G.Influence of the deprivation of a single amino acid on cellular proliferation and survival in rat 3Y1 fibroblasts and their derivatives transformed by a wide variety of agents . J. Cell. Physiol. , 136 , 421 – 430 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Chen , H. J. , Treweeke , A. T. , Ke , Y. Q. , West , D. C. and Toh , C. H.Angiogenically active vascular endothelial growth factor is over‐expressed in malignant human and rat prostate carcinoma cells . Br. J. Cancer , 82 , 1694 – 1701 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Jing , C. , Beesley , C. , Foster , C. S. , Chen , H. , Rudland , P. S. , West , D. C. , Fujii , H. , Smith , P. H. and Ke , Y.Human cutaneous fatty acid‐binding protein induces metastasis by up‐regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells . Cancer Res. , 61 , 4357 – 4364 ( 2001. ). [PubMed] [Google Scholar]
  • 17. ) Sakamoto , M. , Takamura , M. , Ino , Y. , Miura , A. , Genda , T. and Hirohashi , S.Involvement of c‐Src in carcinoma cell motility and metastasis . Jpn. J. Cancer Res. , 92 , 941 – 946 ( 2001. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Miyado , K. , Sato , M. and Taniguchi , S.Transformation‐related expression of a low‐molecular‐mass tropomyosin isoform TM5/TM30nm in transformed rat fibroblastic cell lines . J. Cancer Res. Clin. Oncol. , 123 , 331 – 336 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Herman , I. M. , Crisona , N. J. and Pollard , T. D.Relation between cell activity and the distribution of cytoplasmic actin and myosin . J. Cell Biol. , 90 , 84 – 91 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Danninger , C. and Gimona , M.Live dynamics of GFP‐calponin: isoform‐specific modulation of the actin cytoskeleton and autoregulation by C‐terminal sequences . J. Cell Sci. , 113 , 3725 – 3736 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Samaha , F. , Ip , H. , Morrisey , E. , Seltzer , J. , Tang , Z. , Solway , J. and Parmacek , M.Developmental pattern of expression and genomic organization of the calponin‐h1 gene . J. Biol. Chem. , 271 , 395 – 403 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Horiuchi , A. , Nikaido , T. , Ya‐Li , Z. , Ito , K. , Orii , A. and Fujii , S.Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of α‐smooth muscle actin, calponin h1, and p27 . Mol. Hum. Reprod. , 5 , 139 – 145 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Fukuda , K. , Kawata , S. , Tamura , S. , Matsuda , Y. , Inui , Y. , Igura , T. , Inoue , S. , Kudara , T. and Matsuzawa , Y.Transforming growth factor‐β1–induced degradation of activated Src tyrosine kinase in rat fibroblasts . Oncogene , 16 , 3349 – 3356 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Fidler , I. J. and Ellis , L. M.The implications of angiogenesis for the biology and therapy of cancer metastasis . Cell , 79 , 185 – 188 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Dvorak , H. , Brown , L. , Detmar , M. and Dvorak , A.Review: vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis . Am. J. Pathol. , 146 , 1029 – 1039 ( 1995. ). [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Takahashi , Y. , Cleary , K. R. , Mai , M. , Kitadai , Y. , Bucana , C. D. and Ellis , L. M.Significance of vessel count and vascular endothelial growth factor and its receptor (kdr) in intestinal type gastric cancer . Clin. Cancer Res. , 2 , 1679 – 1684 ( 1996. ). [PubMed] [Google Scholar]
  • 27. ) Neufeld , G. , Cohen , T. , Gengrinovitch , S. and Poltorak , Z.Vascular endothelial growth factor (VEGF) and its receptors . FASEB J. , 13 , 9 – 22 ( 1999. ). [PubMed] [Google Scholar]
  • 28. ) Beierie , E. A. , Strande , L. F. and Chen , M. K.VEGF upregulates Bcl–2 expression and is associated with decreased apoptosis in neuroblastoma cells . J. Pediatr. Surg. , 37 , 467 – 471 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Bias , S. , Choy , M. , Alitalo , K. and Rafii , S.Vascular endothelial growth factor (VEGF)‐C signaling through FLT–4 (VEGFR–3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy . Blood , 99 , 2179 – 2184 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Marschall , Z. V. , Cramer , T. , Hocker , M. , Burde , R. , Plath , T. , Schirner , M. , Heidenreich , R. , Breier , G. , Riecken , E.‐O. , Wiedenmann , B. and Rosewicz , S.De novo expression of vascular endothelial growth factor in human pancre atic cancer: evidence for an autocrine mitogenic loop . Gastroenterology , 119 , 1358 – 1372 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Miralem , T. , Steinberg , R. , Price , D. and Avraham , H.VEGF165 requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells . Oncogene , 20 , 5511 – 5524 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Fiedler , W. , Graeven , U. , Ergun , S. , Verago , S. , Kilic , N. , Stockschlader , M. and Hossfeld , D. K.Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia . Blood , 89 , 1870 – 1875 ( 1997. ). [PubMed] [Google Scholar]
  • 33. ) Niu , G. , Wright , K. L. , Huang , M. , Song , L. , Haura , E. , Turkson , J. , Zhang , S. , Wang , T. , Sinibaldi , D. , Coppola , D. , Heller , R. , Ellis , L. M. , Karras , J. , Bromberg , J. , Pardoll , D. , Jove , R. and Yu , H.Constitutive Stat3 activity up‐regulates VEGF expression and tumor angiogenesis . Oncogene , 21 , 2000 – 2008 ( 2002. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Jiang , B.‐H. , Aganai , F. , Passaniti , A. and Semenza , G. L.V‐src induces expression of hypoxia‐inducible factor 1 (HIF–1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF1 in tumor progression . Cancer Res. , 57 , 5328 – 5335 ( 1997. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES